A third study on the use of orally administered anhydrous crystalline maltose for relief of dry mouth in primary Sjögren's syndrome

Journal of Alternative and Complementary Medicine

Volumn 8, Issue 5, 2002, Pages 651-659

  Fox, Philip C ^a   Cummins, Martin J ^a   Cummins, Joseph M ^a  

^a Amarillo Biosciences Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANETHOLE TRITHIONE; BROMHEXINE; CEVIMELINE; MALTOSE; PILOCARPINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; LOZENGE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RATING SCALE; SAFETY; SIDE EFFECT; SJOEGREN SYNDROME; SYMPTOM; UNITED STATES; XEROSTOMIA;

EID: 0036803914     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/107555302320825174     Document Type: Article

References (38)

1. Atkinson JC, Fox PC. Sjögren's syndrome: Oral and dental considerations. J Am Dent Assoc 1993;124:74-86.
2. Butt GM. Drug-induced xerostomia. J Can Dent Assoc 1991;57:391-393.
3. Chaushu G, Bercovici M, Dori S, Waller A, Taicher S, Kronenberg J, Talmi YP. Salivary flow and its relation with oral symptoms in terminally ill patients. Cancer 2000;88:984-987.
4. Daniels TE. Sjögren's syndrome: Clinical spectrum and current diagnostic controversies. Adv Dent Res 1996;10:3-8.
5. Drosos AA, Andonopoulos AP, Costopoulos JS, Papadimitriou CS, Moutsopoulos HM. Prevalence of primary Sjögren's syndrome in an elderly population. Br J Rheumatol 1988;27:123-127.
6. Forbes K. Palliative care in subjects with cancer of the head and neck. Clin Otolaryngol 1997;22:117-122.
7. Fox PC. Management of dry mouth. Dent Clin North Am 1997a;41:863-876.
8. Fox PC, Cummins MJ, Cummins JM. Use of orally administered crystalline maltose for relief of dry mouth. J Altern Complement Med 2001;7:33-43.
9. Fox PC, van der Ven PF, Sonies BC, Weiffenbach JM, Baum BJ. Xerostomia: Evaluation of a symptom with increasing significance. J Am Dent Assoc 1985;110:519-525.
10. Fox RI. Clinical features, pathogenesis, and treatment of Sjögren's syndrome. Curr Opin Rheumatol 1996;8:438-445.
11. Fox RI. Sjögren's syndrome. Controversies and progress. Clin Lab Med 1997b;17:431-444.
12. Fox RI, Howell FV, Bone RC, Michelson P. Primary Sjögren's syndrome: Clinical and immunopathologic features. Semin Arthritis Rheum 1984;14:77-105.
13. Fox RI, Maruyama T. Pathogenesis and treatment of Sjögren's syndrome. Curr Opin Rheumatol 1997;9:393-399.
14. Friedlander AH, West LJ. Dental management of the patient with major depression. Oral Surg Oral Med Oral Pathol 1991;71:573-578.
15. Friedlaender MH. Ocular manifestations of Sjögren's syndrome: Keratoconjunctivitis sicca. Rheum Dis Clin North Am 1992;18:591-608.
16. Fritzler MJ, Pauls JD, Kinsella TD, Bowen TJ. Antinuclear, anticytoplasmic, and anti-Sjögren's syndrome antigen A (SS-A/Ro) antibodies in female blood donors. Clin Immunol Immunopathol 1985;36:120-128.
17. Gilbert GH, Heft MW, Duncan RP. Mouth dryness as reported by older Floridians. Community Dent Oral Epidemiol 1993;21:390-397.
18. Jacobs C. The internist in the management of head and neck cancer. Ann Intern Med 1990;113:771-778.
19. Karlsson K-A. Glycobiology: A growing field for drug design. Trend Pharmacol Sci 1991;12:265-272.
20. Locker D. Subjective reports of oral dryness in an older adult population. Community Dent Oral Epidemiol 1993;21:165-168.
21. Mang FW, Michieletti KPL, O'Rourke K, Cauch-Dudek K, Diamant N, Bookman A, Heathcote J. Primary biliary cirrhosis, sicca complex, and dysphagia. Dysphagia 1997;12:167-170.
22. Mulligan R, Navazesh M, Wood GJ. A pilot study comparing three salivary collection methods in an adult population with salivary gland hypofunction. Spec Care Dent 1995;15:154-157.
23. Myssiorek D, Alvi A, Bhuyia T. Primary salivary gland amyloidosis causing sicca syndrome. Ann Otol Rhinol Laryngol 1992;101:487-490.
24. Navazesh M. Methods for collecting saliva. Ann NY Acad Sci 1993;694:72-77.
25. Persson RE, Izutsu KT, Treulove EL, Persson R. Differences in salivary flow rates in elderly subjects using xerostomatic medications. Oral Surg Oral Med Oral Pathol 1991;72:42-46.
26. Peterson DE, Sonis ST. Oral complications of cancer chemotherapy: Present status and future studies. Cancer Treat Rep 1982;66:1251-1256.
27. Romero PM, De Diego LA, Rivera J, Garcia MA, Piqueras AB, Garcia DF, Cos AE, Clemente RG. Rheumatologic and autoimmune manifestations in patients with chronic hepatitis C virus infection. Rev Esp Enferm Dig 1997;89:591-598.
28. Sharon N. Lectin receptors as lymphocyte surface markers. Adv Immunol 1983;34:213-298.
29. Sharon N, Lis H. Lectins as cell recognition molecules. Science 1989;246:227-234.
30. Sherson W, Taylor B. Xerostomia in an HIV positive cohort [poster no. P33]. Annual Conference/Australasian Society for HIV Medicine 1997;9:132.
31. Smith RG, Burtner AP. Oral side-effects of the most frequently prescribed drugs. Spec Care Dentist 1994;14:96-102.
32. Sreebny LM. Drugs and dry mouth-treating drug-induced xerostomia. Moisture Seekers Newsletter 2000;18:5.
33. Stefaniotis TD, Donta CN. Incidence of xerostomia in patients with drug-controlled diabetes mellitus. Hell Stomatol Chron 1990;34:97-101.
34. Strickland RW, Tesar JT, Berne BH, Hobbs BR, Lewis DM, Welton RC. The frequency of sicca syndrome in an elderly female population. J Rheum 1987;14:766-771.
35. Talal N. What is Sjögren's syndrome and why is it important? J Rheumatol 2000;27(Suppl 61):1-3.
36. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, Bjerrum KB, Braga S, Coll J, de Vita S, Drosos AA, Ehrenfeld M, Hatron PY, Hay EM, Isenberg DA, Janin A, Kalden JR, Kater L, Konttinen YT, Maddison PJ, Maini RN, Manthorpe R, Meyer O, Ostuni P, Pennec Y, Prause JU, Richards A, Sauvezie B, Schiodt M, Sciuto M, Scully C, Shoenfeld Y, Skopouli FN, Smolen JS, Snaith ML, Tishler M, Todesco S, Valesini G, Venables PJW, Wattiaux MJ, Youinou P. (Results of a prospective concerted action supported by the European Community). Preliminary criteria for the classification of Sjögren's syndrome. Arthritis Rheum Dis 1993;36:340-347.
37. Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY, Kater L, Konttinen YT, Manthorpe R, Meyer O, Mosca M, Ostuni P, Pellerito RA, Pennec Y, Porter SR, Richards A, Sauvezie B, Schiodt M, Sciuto M, Shoenfeld Y, Skopouli FN, Smolen JS, Soromenho F, Tishler M, Tomsic M, van de Merwe JP, Yeoman CM, Wattiaux MJ. (The European Study Group on Diagnostic Criteria for Sjögren's Syndrome). Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: Results of a prospective multicentre study. Ann Rheum Dis 1996;55:116-21.
38. Wu AJ, Fox PC. Sjögren's syndrome. Semin Dermatol 1994;13:138-143.